SMS Lifesciences Share Price

₹ 1,425.00

+₹30.60 (2.19%)
1D
Last updated 02 Nov, 2026, 15:29 IST
NSE: HALEOSLABS
|
Pharmaceuticals

SMS Lifesciences Share Price Today

As of 3 Nov 2026, SMS Lifesciences share price is ₹1,425.00. The stock opened at ₹1,422.20, compared to its previous close of ₹1,394.40. During today's trading session, SMS Lifesciences share price moved in the range of ₹1,391.10 to ₹1,425.00, with an average price of ₹1,408.05 for the day. Looking at its last 52-week, the stock has touched a low of ₹1,091.10 and a high of ₹1,774.00. On the performance front, SMS Lifesciences share price has declined by 2.18% over the last six months and is up 20.58% on a year-on-year basis.

Share price over the last 1 day rose from 1423.00 to 1425.00, ranging between 1391.10 and 1425.00.
₹1,391.10
2.19% up today
₹1,425.00
1D LOW
1D HIGH

SMS Lifesciences Stock Insights

Latest Earning
Op Profit TrendUp by 278.02% QoQ
Latest Earning
Net Profit TrendUp by 441.18% QoQ
Latest Earning
Revenue TrendDown by 4.86% QoQ
Stock Performance
OutperformingBeat Nifty by 26.99 % in last 1 year
SMS Lifesciences stock performance
Open₹1,422.20
High₹1,425.00
Low₹1,391.10
Prev. close₹1,394.40
SMS Lifesciences trading activity
Volume838
Average traded price₹1,424.54
Last traded time03:29:38 02 Nov
Last traded quantity54
Circuit
L
H
₹1,115.60
₹1,673.20
52-week
L
H
₹1,091.10
₹1,774.00
Mkt Cap Cr
410.93
P/E
26.93
P/B
1.92
ROA
3.36%
ROE
8.11%
ROCE
9.76%
Quick Ratio
0.53
EV/EBITDA
12.05

Based on fundamentals, this stock's

Performance: 1 out of 5, Very Poor
Performance
Very Poor
Haleos Labs Limited has not beaten FD return of 7%
Valuation: 1 out of 5, Overvalued
Valuation
Overvalued
Haleos Labs Limited appears overvalued compared to its peers
Earnings: 3 out of 5, Neutral
Earnings
Neutral
Haleos Labs Limited earnings growth is positive
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROAROEROCEQuick RatioEV/EBITDA
Sun Pharmaceutical Industries4,24,202.4238.834.789.61%13.79%18.65%2.3122.27
Divis Laboratories2,57,902.7388.1715.3914.6%15.32%19.56%3.558.97
Torrent Pharmaceuticals1,76,306.2184.09.64.7%11.42%11.37%0.7533.6
Laurus Labs1,29,242.6897.021.3311.58%22.11%20.91%0.6854.77
Zydus Lifesciences1,24,089.4827.024.588.57%18.59%17.35%0.9116.42
Dr. Reddy's Laboratories1,12,698.5340.842.94.79%7.21%8.58%1.3519.05
Cipla1,11,486.1439.063.156.6%8.18%10.8%2.521.03
Mankind Pharma1,02,796.6045.425.857.82%12.76%14.68%0.7425.01
Aurobindo Pharma96,536.9026.022.556.34%9.25%11.76%1.1512.38
Lupin91,870.1616.554.0914.47%23.76%24.88%1.429.83

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

SMS Lifesciences Company Background

ISIN
INE320X01016
Sector Market Cap
₹ 410.93 Cr

Haleos Labs Limited, formerly, SMS Lifesciences India Limited, is an India-based company that is engaged in the business of manufacturing of active pharma ingredients (API) and their intermediates. The Company's API products include Ranitidine Hydrochloride (Form-2) USP / Ph. Eur / IP, Famotidine USP / Ph. Eur / IP, Sildenafil Citrate USP / Ph. Eur / IP, Allopurinol USP / EP / IP, Ropivacaine Hydrochloride USP / EP / IP, Dapsone USP/ EP /BP, Sibutramine Hydrochloride USP, Itraconazole USP / Ph. Eur, Fosphenytoin Sodium USP, Domperidone / Domperidone Maleate EP / IP, Brinzolamide, Tiagabine, Fosaprepitant and Albendazole, among others. Its intermediate offerings include Ranitidine HCl Intermediates, Rizatriptan Intermediates and Imidapril Intermediates. The Company's manufacturing facilities are located at Kazipally and Jeedimetla, and its research and development center is at Sanath Nagar in Hyderabad. The Company's wholly owned subsidiary is Mahi Drugs Private Limited.

SMS Lifesciences Financial Highlights

  • Revenue: SMS Lifesciences reported revenue of ₹336.22 crore in FY26 vs ₹349.58 crore in FY25. It showed a decrease of 3.82% on a yearly basis.
  • Operating Profit: SMS Lifesciences reported an operating profit of ₹25.20 crore in FY26 vs ₹26.19 crore in FY25. It showed a decrease of 3.78% on a year-on-year basis.
  • Net Profit: SMS Lifesciences reported a net profit of ₹17.80 crore in FY26 vs ₹18.73 crore in FY25. It showed a decrease of 4.97% on a yearly basis.

SMS Lifesciences Quarterly Result Highlights

  • SMS Lifesciences reported revenue of ₹73.40 crore in Jun 2026, compared with ₹77.15 crore in Mar 2026, representing a decrease of 4.86% on a quarter-on-quarter (QoQ) basis.
  • SMS Lifesciences reported an operating profit of ₹3.44 crore in Jun 2026, compared with ₹0.91 crore in Mar 2026, representing an increase of 278.02% on a quarter-on-quarter (QoQ) basis.
  • SMS Lifesciences reported a profit of ₹1.84 crore in Jun 2026, compared with ₹0.34 crore in Mar 2026, reflecting an increase of 441.18% on a QoQ basis.
  • The earnings per share (EPS) of SMS Lifesciences stood at ₹57.26 during Jun 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Promoters
72.11%
FII
0.00%
Other DII
0.31%
Retail and other
27.58%
Mutual funds
0.00%
Foreign Institutional Investor (FII)
FII shareholding by period
Dec 20250.00%
Mar 20260.00%
Jun 20260.00%
Sep 20260.00%

SMS Lifesciences Investment Returns

1 day
+2.19%
1 week
-2.64%
1 month
-4.36%
1 year
+20.58%
3 years
+188.02%
5 years
+67.46%

SMS Lifesciences Share Price History

SMS Lifesciences share price history by day, showing open and close prices and the percentage change
Day
Open / Close
Change %
02 Nov 26
₹1,422.20 / ₹1,425.00
+2.19%
30 Oct 26
₹1,426.10 / ₹1,394.40
-2.43%
29 Oct 26
₹1,450.40 / ₹1,429.20
-1.48%
28 Oct 26
₹1,474.00 / ₹1,450.60
-1.59%
Show more

SMS Lifesciences Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹333.79₹344.72₹305.96₹315.56
Other Income₹2.43₹4.86₹3.83₹3.07
Total Revenue₹336.23₹349.58₹309.79₹318.63
Total Expenses₹311.03₹323.39₹299.94₹304.39
Profit Before Tax₹25.20₹26.19₹9.85₹16.59
Tax₹7.40₹7.46₹3.52₹5.22
Profit After Tax₹17.80₹18.73₹6.33₹11.38
EPS - Basic₹57.26₹66.51₹30.08₹37.92
EPS - Diluted₹57.26₹66.51₹30.08₹37.92

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹25.20₹26.19₹9.85₹14.24
Income before WC changes₹42.87₹50.91₹31.33₹30.11
Change in Assets-₹55.26-₹49.93-₹40.32-₹31.16
Change in Liabilities₹56.11₹41.57₹36.30₹19.01
Change in WC₹0.85-₹8.36-₹4.03-₹12.15
Cash flow from Operations₹37.22₹34.05₹24.31₹14.70
Cash flow from Investing-₹57.90-₹15.00-₹18.45-₹31.29
Cash flow from Financing₹21.38-₹19.12-₹6.56₹16.89
Total Cash Flow₹0.71-₹0.07-₹0.71₹0.29
Cash (Start of the year)₹0.50₹0.57₹1.28₹0.99
Cash (End of the year)₹1.21₹0.50₹0.57₹1.28

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹291.30₹239.42₹235.25₹235.77
Current Assets₹163.11₹150.57₹156.08₹159.12
Total Assets₹454.41₹389.99₹391.33₹394.89
Current Liabilities₹156.28₹142.07₹145.37₹133.56
Net Current Asset₹6.83₹8.51₹10.71₹25.55
Non-Current Liabilities₹68.57₹35.88₹52.32₹73.11
Equity Capital₹229.56₹212.05₹193.64₹188.22
Total Equity & Liabilities₹454.41₹389.99₹391.33₹394.89

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹300.99₹333.37₹300.00₹315.24
Other Income₹1.42₹3.95₹3.84₹2.88
Total Revenue₹302.41₹337.32₹303.84₹318.12
Total Expenses₹277.22₹307.28₹284.73₹302.10
Profit Before Tax₹25.19₹30.04₹19.11₹18.37
Tax₹7.41₹8.67₹6.05₹5.15
Profit After Tax₹17.78₹21.37₹13.07₹13.22
EPS - Basic₹58.80₹70.69₹43.22₹43.72
EPS - Diluted₹58.80₹70.69₹43.22₹43.72

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹25.19₹30.04₹19.11₹16.02
Income before WC changes₹37.60₹48.89₹34.51₹27.53
Change in Assets-₹2.85-₹9.82-₹6.97-₹7.49
Change in Liabilities₹10.18-₹2.54-₹9.79-₹11.97
Change in WC₹7.33-₹12.36-₹16.76-₹19.45
Cash flow from Operations₹38.43₹28.03₹14.75₹4.58
Cash flow from Investing-₹49.28-₹13.77-₹13.75-₹27.96
Cash flow from Financing₹10.85-₹14.20-₹0.82₹22.59
Total Cash Flow₹0.00₹0.07₹0.18-₹0.80
Cash (Start of the year)₹0.40₹0.33₹0.15₹0.95
Cash (End of the year)₹0.40₹0.40₹0.33₹0.15

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹221.63₹180.52₹172.88₹169.80
Current Assets₹181.71₹177.79₹175.35₹167.59
Total Assets₹403.34₹358.31₹348.24₹337.39
Current Liabilities₹133.02₹124.30₹123.56₹110.57
Net Current Asset₹48.69₹53.49₹51.79₹57.03
Non-Current Liabilities₹55.74₹36.84₹48.45₹62.80
Equity Capital₹214.58₹197.18₹176.23₹164.03
Total Equity & Liabilities₹403.34₹358.31₹348.24₹337.39
* All values are in INR Crore
SMS Lifesciences market depth
Bid quantityBid priceAsk priceAsk quantity
0000
0000
0000
0000
0000
Total bid quantity0
Total ask quantity0
SMS Lifesciences technical summary
Bearish indicators2
Neutral indicators3
Bullish indicators3
OverallSlightly Bullish
by SEBI experts

Expert Pick

EXPPICK
Stop-loss
Stop-loss is locked. Sign in to view.
Entry price
Entry price is locked. Sign in to view.
Target
Target is locked. Sign in to view.
Indicator
Value
Verdict
RSI (14)
32.91
Neutral
ATR (14)
54.65
Neutral
STOCH(9,6)
4.58
Bullish
STOCH RSI (14)
0
Bullish
ADX(9)
27.56
Bearish
UO(9)
33.76
Neutral
ROC(12)
-9.81
Bearish
WillR(14)
-95.42
Bullish
Period
Simple value
Exponential vaue
5D
1442.38
1443.36
10D
1497.62
1477.4
20D
1526.8
1500.64
50D
1501.85
1505.58
100D
1499.83
1490.08
Volume trend — traded volume by day
2 Nov0L
30 Oct0L
29 Oct0L
28 Oct0L
27 Oct0L
Average0L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks

SMS Lifesciences
Pharmaceuticals
Add Stock
Add Another

SMS Lifesciences Returns Calculator

Ex-date: 23 Sep 2026

Top Gainers

ITI Share Price
₹259.14
+43.19 (+20%)
ENGINERSIN Share Price
₹289.65
+37.8 (+15.01%)
AFFLE Share Price
₹1506.50
+164.7 (+12.27%)
PRAJIND Share Price
₹271.13
+29.43 (+12.18%)
DIXON Share Price
₹12319.00
+1319 (+11.99%)
See more

Top Losers

INDIGOPNTS Share Price
₹870.00
-127.3 (-12.76%)
CLEAN Share Price
₹662.60
-53 (-7.41%)
ZEEL Share Price
₹61.58
-4.82 (-7.26%)
SYRMA Share Price
₹1512.00
-113.3 (-6.97%)
POLICYBZR Share Price
₹931.00
-69.1 (-6.91%)
See more

SMS Lifesciences Share Price FAQs

Please be aware that SMS Lifesciences stock prices are subject to continuous fluctuations due to various factors.